Preliminary results from the Australian Genetics of Bipolar Disorder Study: A nation-wide cohort
CONCLUSION: Our findings highlight the high rate of comorbidities and adverse drug reactions among adults living with bipolar disorder in the general Australian population. Future genomic analyses focus on identifying genetic variants influencing pharmacotherapy treatment response and side effects.PMID:37655588 | DOI:10.1177/00048674231195571
Source: The Australian and New Zealand Journal of Psychiatry - Category: Psychiatry Authors: Penelope A Lind Dan J Siskind Ian B Hickie Luc ía Colodro-Conde Simone Cross Richard Parker Nicholas G Martin Sarah E Medland Source Type: research
More News: Anxiety | Australia Health | Bipolar | Carbamazepine | Depression | Drugs & Pharmacology | Generalized Anxiety Disorder (GAD) | Genetics | Health Management | Lithium | Lithium Carbonate | Mania | Medicare | New Zealand Health | Psychiatry | Study